Text Correction
In the published article, there was an error. [There is a spelling mistake by writing “NS5 protease inhibitors” in key words on page 1 and in one of the subheadings named “NS5 Protease Inhibitors” on page 4].
A correction has been made to [“Key words” and “THE DEVELOPMENT OF ANTI-ZIKV THERAPEUTICS”], [NS5 Protease Inhibitors], [the subheading of “NS5 Protease Inhibitors”]. This sentence previously stated: “[NS5 Protease Inhibitors]”
The corrected sentence appears below: “[NS5 Protein Inhibitors]”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Zika virus, pathogenesis, therapeutics, NS2B–NS3 protease inhibitors, NS3 protease inhibitors, NS5 protein inhibitors, E protein inhibitors, host protein inhibitors
Citation
Li K, Ji Q, Jiang S and Zhang N (2022) Corrigendum: Advancement in the development of therapeutics against Zika virus infection. Front. Cell. Infect. Microbiol. 12:1006226. doi: 10.3389/fcimb.2022.1006226
Received
29 July 2022
Accepted
03 August 2022
Published
26 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Li, Ji, Jiang and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shibo Jiang, shibojiang@fudan.edu.cn; Naru Zhang, zhangnr@zucc.edu.cn
This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.